Shandong Weigao Group Medical Polymer Company Limited
SHWGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $24,951,288 | $22,815,531 | $32,199,994 | $31,394,984 |
| - Cash | $8,945,180 | $7,780,310 | $7,527,635 | $6,988,731 |
| + Debt | $5,512,567 | $4,193,146 | $4,129,119 | $4,169,317 |
| Enterprise Value | $21,518,675 | $19,228,367 | $28,801,478 | $28,575,570 |
| Revenue | $6,644,048 | $6,451,383 | $6,635,688 | $6,331,753 |
| % Growth | 3% | -2.8% | 4.8% | – |
| Gross Profit | $3,303,508 | $3,159,129 | $3,376,443 | $3,067,291 |
| % Margin | 49.7% | 49% | 50.9% | 48.4% |
| EBITDA | $1,638,396 | $1,497,618 | $1,697,837 | $1,384,280 |
| % Margin | 24.7% | 23.2% | 25.6% | 21.9% |
| Net Income | $1,008,317 | $959,119 | $1,107,549 | $804,139 |
| % Margin | 15.2% | 14.9% | 16.7% | 12.7% |
| EPS Diluted | 0.22 | 0.2 | 0.24 | 0.178 |
| % Growth | 10% | -16.7% | 35.1% | – |
| Operating Cash Flow | $881,573 | $1,767,197 | $1,022,774 | $1,681,378 |
| Capital Expenditures | $0 | -$598,046 | $0 | -$647,577 |
| Free Cash Flow | $881,573 | $1,169,151 | $1,022,774 | $1,033,801 |